Skip to navigation Skip to content



About this Medication
  • Brand Name: Nuedexta (U.S.)
  • Chemical Name: dextromethorphan hydrobromide + quinidine sulfate
  • Usage in MS: Pseudobulbar Affect
  • Generic Available: No


Nuedexta is a combination of dextromethorphan hydrobromide and quinidine sulfate. It is approved by the U.S. Food and Drug Administration (FDA) to treat pseudobulbar affect (uncontrolled episodes of crying and/or laughing that are disconnected from or out of proportion to what the person is feeling at the time) in people with multiple sclerosis and other neurological diseases.

For more information about the medication and the Nuedexta reimbursement support services, call 1-855-468-3339.

Click here to read the Nuedexta Prescribing Information for healthcare professionals.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.